Polycystic Ovarian Syndrome: Prevalence and Impact on the Wellbeing of Australian Women Aged 16-29 Years

October 2017 in “ Australian & New Zealand Journal of Obstetrics & Gynaecology ”

L. Chitra Varanasi, Asvini K Subasinghe, Yasmin Jayasinghe, Emma T. Callegari, Suzanne M. Garland, Alexandra Gorelik, John D. Wark

Polycystic Ovarian Syndrome PCOS National Institutes of Health criteria NIH criteria fertility issues

TLDR Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

The study investigated the prevalence of Polycystic Ovarian Syndrome (PCOS) in a sample of Australian women aged 16-29 and its impact on their wellbeing. It found a 12% prevalence rate using the National Institutes of Health (NIH) criteria, with a discrepancy between self-reported PCOS (8%) and NIH criteria diagnosis (12%). The study revealed that only 35% of self-reported cases were confirmed by NIH criteria, indicating potential over-diagnosis and the resulting unnecessary stress, particularly concerning fertility issues. The research, which included 254 participants for NIH criteria prevalence and 300 for self-reported prevalence, highlighted the need for standardized diagnostic criteria and better education on PCOS to prevent undue anxiety.

View this study on obgyn.onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

Consensus on Women's Health Aspects of Polycystic Ovary Syndrome: The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

research Consensus on Women's Health Aspects of Polycystic Ovary Syndrome: The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

1514 citations, December 2011 in “Fertility and sterility”

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

research Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1744 citations, August 2006 in “The Journal of Clinical Endocrinology and Metabolism”

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome

4809 citations, January 2004 in “Fertility and Sterility”

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Related Community Posts Join

6 / 12 results

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 3 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Bryan Johnson just dropped his anti hair loss formula

in Treatment 339 upvotes 9 months ago

Bryan Johnson shared his hair loss treatment, which mainly relies on minoxidil and finasteride. Some users are skeptical of his results, while others appreciate his efforts in anti-aging and hair loss research.

community 21F AGA - 4 month hair growth progress (Minoxidil 5%, finasteride 1mg, theradome LLLT, viviscal vitamins, PRP twice)

in Progress Pictures 257 upvotes 2 years ago

A 21-year-old female shared her 4-month hair growth progress using Minoxidil 5%, finasteride 1mg, Theradome LLLT, Viviscal vitamins, and PRP treatments twice. Commenters praised her progress and discussed other treatments like microneedling, but she noted her dermatologist advised against it due to potential scalp damage.

community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

in Female 56 upvotes 1 year ago

A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

community having hair loss as a teen SUCKS. A LOT.

in Female 12 upvotes 2 years ago

A teenage girl who has been diagnosed with ADA and is struggling with hair loss, which has caused her to lose confidence. She is looking for recommendations on treatments such as finasteride or Minoxidil, and lifestyle advice including vitamins and other supplements that might help with the issue.

community My scalp punch biopsy results🤔?

in Female 8 upvotes 1 year ago

Female using Rogaine foam for hair loss had scalp punch biopsy, diagnosed with Androgenetic Alopecia (AGA). Doctor recommended starting Spironolactone 50mg.

Related Research

1 / 1 results

research Polycystic Ovary Syndrome: Clinical Aspects

27 citations, April 1996 in “Baillière's clinical endocrinology and metabolism”

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.